Search Results

You are looking at 121 - 130 of 203 items for :

  • Refine by Access: All x
Clear All
Full access

Merav Bar and Jerald Radich

3.2 months, respectively. The most common side effects reported in the clinical trial include hypertension, rash, abdominal pain, fatigue, headache, dry skin, constipation, fever, joint pain, and nausea. Arterial thrombosis and liver toxicity were

Full access

Jeffrey S. Montgomery, David C. Miller, and Alon Z. Weizer

to 71% of patients experiencing urinary frequency, 67% cystitis, 25% fever, and 23% hematuria. Serious local and systemic infections from BCG occur and may require antituberculosis therapy and even hospitalization. Although the use of BCG should be

Full access

Agda Karina Eterovic, Ossama M. Maher, Joya Chandra, Ken Chen, Jason Huse, and Wafik Zaky

treatment was stopped because disseminated fungal infection was suspected after the patient developed fever and neutropenia, and CT of the liver showed some nodularity but blood culture results were negative. Antifungal therapy was initiated for a total of 6

Full access

Michael J. Berger, David S. Ettinger, Jonathan Aston, Sally Barbour, Jason Bergsbaken, Philip J. Bierman, Debra Brandt, Dawn E. Dolan, Georgiana Ellis, Eun Jeong Kim, Steve Kirkegaard, Dwight D. Kloth, Ruth Lagman, Dean Lim, Charles Loprinzi, Cynthia X. Ma, Victoria Maurer, Laura Boehnke Michaud, Lisle M. Nabell, Kim Noonan, Eric Roeland, Hope S. Rugo, Lee S. Schwartzberg, Bridget Scullion, John Timoney, Barbara Todaro, Susan G. Urba, Dorothy A. Shead, and Miranda Hughes

serious skin reaction (drug reaction with eosinophilia and systemic symptoms [DRESS]) (see prescribing information), but other symptoms include a fever with a rash and swollen lymph glands, or swelling in the face; patients with these symptoms should seek

Full access

Brad Zebrack, Karen Kayser, Deborah Bybee, Lynne Padgett, Laura Sundstrom, Chad Jobin, and Julianne Oktay

psychological…social, and/or spiritual nature that may interfere with the ability to cope effectively with cancer, its physical symptoms, and its treatment.” 7 Distress is not a diagnosable disorder. Like fever or high blood pressure, distress is an indicator

Full access

Van K. Morris and Cathy Eng

disease. Most patients (56%) who received all planned doses per protocol remained alive after 12 months on study. All patients experienced treatment-related AEs, most of which were infusion-related reactions, including fevers, chills, and fatigue. Given

Full access

Abi Vijenthira, Lee Mozessohn, Chenthila Nagamuthu, Ning Liu, Danielle Blunt, Shabbir Alibhai, Anca Prica, and Matthew C. Cheung

spent a significantly longer number of days in the hospital compared with nonfrail patients. During both time frames, the top 3 reasons for admission among both frail and nonfrail patients were fever/infection/neutropenia, lymphoma, and symptom

Full access

Ganessan Kichenadasse, John O. Miners, Arduino A. Mangoni, Andrew Rowland, Ashley M. Hopkins, and Michael J. Sorich

other cancer types or ICIs. Third, the data had investigator-reported AEs and there was no external validation/confirmation of AEs. Finally, the irAEs analyzed were organ-specific, and did not include constitutional symptoms such as fatigue and fever

Full access

Daniel E. Lage, Areej El-Jawahri, Charn-Xin Fuh, Richard A. Newcomb, Vicki A. Jackson, David P. Ryan, Joseph A. Greer, Jennifer S. Temel, and Ryan D. Nipp

.4% (n=72) had breast cancer; 31.5% (n=306) had another cancer type ( Table 1 ). Reasons for admission included symptom management (56.0%; n=544); fever or infections (24.6%; n=239); fatigue, weakness, or failure to thrive (13.5%; n=131); and metabolic

Full access

P. Connor Johnson, Caron Jacobson, Alisha Yi, Anna Saucier, Tejaswini M. Dhawale, Ashley Nelson, Mitchell W. Lavoie, Mathew J. Reynolds, Carlisle E.W. Topping, Matthew J. Frigault, and Areej El-Jawahri

determine reasons for hospital readmissions. 12 In the schema for our study, these reasons included symptoms, fever without a source, febrile neutropenia, confirmed infection, dehydration/electrolyte abnormalities, planned hospitalization